ABSTRACT Introduction: This study aims to explore awareness, knowledge, and diagnostic/therapeutic practices in monogenic uveitis (mU) among uveitis experts. Methods: This is an explorative, cross-sectional survey study. An anonymous, semi-structured, electronic survey was delivered to uveitis experts from the Autoinflammatory Diseases Alliance (AIDA) Network and International Uveitis Study Group (IUSG). We included respondents answering C 50% of the survey. Results: Seventy-seven participants rated their knowledge of mU as proficient (3.9%), adequate (15.6%), sufficient (16.9%), or poor (63.6%). When asked about the first mU gene they thought of, 60.4% mentioned NOD2, 3.9% mentioned NLRP3 or MEFV, and 49.4% provided incorrect or no answers. Success rates in clinical scenarios varied from 15.6% to 55.8% and were higher for ophthalmologists working
Knowledge and current practices in monogenic uveitis: an international survey by IUSG and AIDA network / Gaggiano, C., Gupta, V., Agrawal, R., De Smet, M.D., Frediani, B., Marco Tosi, G., Paroli, M.P., Sridharan, S., Pavesio, C.E., Pleyer, U., Denisova, E.V., Babu, K., de-la-Torre, A., Yang, P., Davis, J.L., T Cunningham, E., Carreño, E., Goldstein, D., Fonollosa, A., Cantarini, L., et al.. - In: OPHTHALMOLOGY AND THERAPY. - ISSN 2193-6528. - (2023). [10.1007/s40123-023-00839-1]
Knowledge and current practices in monogenic uveitis: an international survey by IUSG and AIDA network
Maria Pia Paroli;Luca Cantarini
;Claudia Fabiani
Ultimo
2023
Abstract
ABSTRACT Introduction: This study aims to explore awareness, knowledge, and diagnostic/therapeutic practices in monogenic uveitis (mU) among uveitis experts. Methods: This is an explorative, cross-sectional survey study. An anonymous, semi-structured, electronic survey was delivered to uveitis experts from the Autoinflammatory Diseases Alliance (AIDA) Network and International Uveitis Study Group (IUSG). We included respondents answering C 50% of the survey. Results: Seventy-seven participants rated their knowledge of mU as proficient (3.9%), adequate (15.6%), sufficient (16.9%), or poor (63.6%). When asked about the first mU gene they thought of, 60.4% mentioned NOD2, 3.9% mentioned NLRP3 or MEFV, and 49.4% provided incorrect or no answers. Success rates in clinical scenarios varied from 15.6% to 55.8% and were higher for ophthalmologists working| File | Dimensione | Formato | |
|---|---|---|---|
|
Caggiano_Knowledge and_2023.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
1.16 MB
Formato
Adobe PDF
|
1.16 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
